Abrysvo act-o-vials
Ended Awarded Last action
- Contract number
- SPE2DR26F66R6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,850
Award facts
- Contract value 100% obligated
- $2,850.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,850.14 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 26, 2026, with a completion date of January 27, 2026. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The parent company is Cencora, Inc., which does business as AmerisourceBergen and holds the underlying $999.99 billion IDC with DLA through December 2026.
This delivery order represents a routine task order execution under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which provides a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, and medical supplies to support military healthcare programs worldwide. The modest order value is consistent with the company's demonstrated capability to fulfill federal medical supply needs across a wide spectrum of transaction sizes, from small-value orders to substantial procurements exceeding $45,000. The supply of ACT-O-VIALS supports critical medical supply chain operations for defense healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F66R6?
SPE2DR26F66R6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F66R6 worth?
The government has obligated $2,850 on SPE2DR26F66R6.
Is contract SPE2DR26F66R6 an order under another contract?
Yes. SPE2DR26F66R6 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66R6 competed?
The extent of competition for SPE2DR26F66R6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award